Wedbush Downgrades Unum Therapeutics (UMRX) to Neutral

March 4, 2020 6:25 AM EST
Get Alerts UMRX Hot Sheet
Price: $2.35 --0%

Rating Summary:
    4 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 11 | New: 8
Trade Now! 
Join SI Premium – FREE

Wedbush analyst David Nierengarten downgraded Unum Therapeutics (NASDAQ: UMRX) from Outperform to Neutral with a price target of $1.00 (from $7.00).

For an analyst ratings summary and ratings history on Unum Therapeutics click here. For more ratings news on Unum Therapeutics click here.

Shares of Unum Therapeutics closed at $0.53 yesterday.

You May Also Be Interested In

Related Categories

Analyst PT Change, Downgrades